Company Overview
About LinusBio
LinusBio is a precision medicine and diagnostics company founded by Manish Arora and headquartered in New York, with roots in research at the Icahn School of Medicine at Mount Sinai and MIT. The company has developed a proprietary technology platform called exposome sequencing — a method of analyzing biological samples, primarily hair, to reconstruct a detailed timeline of environmental exposures and biological changes over months or years. This approach enables early detection of disease risk factors by reading both genetic and environmental signals simultaneously.
Business Model & Competitive Advantage
LinusBio's lead clinical focus is early autism spectrum disorder (ASD) detection. Its research has demonstrated that hair samples from children can reveal exposure patterns — including metal dysregulation and nutritional imbalances — that correlate with autism risk beginning in the prenatal period. By identifying these signals earlier than standard behavioral assessments (which typically diagnose ASD at age 3–4), LinusBio aims to enable interventions during critical neurodevelopmental windows. The company has raised $12.5M in a Series A round to advance its diagnostics toward clinical validation and regulatory submission.
Competitive Landscape 2025–2026
Beyond autism, LinusBio's exposome sequencing platform has potential applications across neurodegenerative diseases, metabolic conditions, and environmental health monitoring. The company represents a novel diagnostic paradigm that sits at the intersection of AI analytics, multi-omics biology, and environmental medicine — addressing the longstanding gap in diagnostics that focus almost exclusively on genetic risk while ignoring environmental co-factors.
Key Differentiators
Emerging Innovator
LinusBio is an emerging player bringing innovative solutions to the Life Sciences & BioTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Schrödinger
Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo
Compare LinusBio with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from LinusBio? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim LinusBio Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention LinusBio vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →